Kisspeptin
Men's HealthSitting one step upstream of GnRH, kisspeptin is the true master regulator of the male HPG axis. Where exogenous testosterone shuts the axis down and HCG bypasses it, kisspeptin signals the hypothalamus itself — making it the most physiological tool available for preserving endogenous testosterone production, fertility, and sexual response in men.
Key Takeaways
Kisspeptin acts one level above GnRH, recruiting the hypothalamus rather than bypassing it like HCG. Targets the KISS1R (GPR54) on GnRH neurons, triggering pulsatile LH and FSH release that remains under normal HPG feedback. Of growing interest in male fertility, testosterone preservation during cycles, and the sexual-brain-processing literature. Pairs naturally with gonadorelin or low-dose CJC-1295 for layered hormonal support. Generally well tolerated in male research populations; affects gonadotropins, so caution in hormone-sensitive conditions.
Male Physiology Mechanism
Kisspeptin's appeal for male physiology lies in the fact that it does not chemically force testosterone production — it asks the body to make it. The result is hormonal support that preserves rather than degrades the endogenous axis.
Upstream of GnRH — the hypothalamic switch
Kisspeptin neurons in the arcuate and anteroventral periventricular nuclei of the hypothalamus express KISS1R (GPR54) on the surface of GnRH neurons. When kisspeptin binds, GnRH is released into the hypophyseal portal system in physiological pulses. This is the same pathway puberty uses, the same pathway dysregulated in hypogonadotropic hypogonadism, and the same pathway suppressed by exogenous testosterone.
TRT compatibility and fertility preservation
Unlike HCG (which directly stimulates Leydig cells and can desensitise the LH receptor over time), kisspeptin re-engages the male brain's own hormonal circuitry. In men on TRT, intermittent kisspeptin dosing has been studied as a means of maintaining testicular volume, intratesticular testosterone, and sperm production — the three things most commonly compromised on long-term exogenous therapy.
Sexual brain processing
Imaging studies show that kisspeptin administration in men activates limbic regions — amygdala, insula, hypothalamus, anterior cingulate — in patterns associated with sexual arousal and emotional processing of erotic stimuli. This effect appears partly independent of testosterone, suggesting a direct central role in male sexual response distinct from its endocrine action.
Male Physiology Applications
Most-studied application in men. Kisspeptin restores LH/FSH signalling in hypothalamic amenorrhea-equivalent male presentations, supports spermatogenesis on long-term TRT, and is being trialled in fertility clinics as a more physiological alternative to HCG.
Men coming off TRT cycles use kisspeptin to re-engage the dormant HPG axis. Unlike clomiphene or enclomiphene (SERMs acting at the pituitary), kisspeptin works upstream at the hypothalamus, restoring true pulsatile GnRH rather than amplifying a damped signal.
Beyond its endocrine effect, kisspeptin produces measurable changes in sexual brain processing in men. Of practical interest for low libido that persists despite normal testosterone, where the limitation is central not peripheral.
In diagnostic settings, kisspeptin challenge can distinguish primary hypothalamic dysfunction from pituitary or testicular causes — useful in workup of unexplained low testosterone in younger men.
Dosing Protocol
| Goal | Route | Dose | Cycle |
|---|---|---|---|
| Fertility / sperm support | SubQ | 100–200 mcg | 1–2× weekly, 8–16 weeks |
| TRT bridge / restart | SubQ | 200 mcg | 2× weekly, 6–12 weeks |
| Sexual response / libido | SubQ | 100–150 mcg | 1–2× weekly, ongoing |
| Diagnostic challenge | IV (clinical) | 0.1–0.3 nmol/kg | Single dose |
Pulsatility matters. Kisspeptin is most physiological when dosed in bursts rather than continuous infusion. Twice-weekly subcutaneous dosing approximates the natural KISS1R activation pattern and avoids the receptor downregulation seen with continuous GnRH analogue exposure.
Stacking
Stacks for the male axis are built layer by layer — hypothalamic, pituitary, gonadal — with kisspeptin sitting at the top.
- Kisspeptin + Gonadorelin: Hypothalamic (kisspeptin) + pituitary (gonadorelin) coverage. Used in TRT-restart protocols where both signals have damped.
- Kisspeptin + Ipamorelin + CJC-1295: Adds GH-axis support for body composition without antagonising the HPG work. The two axes operate independently at this dose range.
- Kisspeptin + PT-141: Pairs hormonal sexual function support (kisspeptin) with central MC4R-mediated sexual response (PT-141). Useful where libido and arousal track separately.
- Kisspeptin alongside TRT: The most common protocol pairing in men's clinics — TRT for steady-state androgen levels, kisspeptin to preserve testicular function and fertility on long-term therapy.
- Avoid alongside continuous GnRH agonist exposure: Receptor downregulation interferes with the kisspeptin signal. Pulsatile dosing of both is required if combined.
Safety & Regulatory Status
Generally well tolerated. Used in fertility research safely. Affects gonadotropins — caution in hormone-sensitive conditions.
Kisspeptin is generally well tolerated in male research cohorts. Because it raises LH and FSH, watch for hormonal volatility in men with pre-existing testicular pathology, prostate cancer history (LH-driven testosterone elevation), or pituitary adenoma. Hot flashes, transient headache, and injection site reactions are uncommon but reported. Not appropriate for prepubertal use except in formal endocrine workup.
Clinical Evidence
Kisspeptin vs Related Peptides
| Compound | Profile | Onset | Best For |
|---|---|---|---|
| Kisspeptin | Hypothalamic upstream | Hours (LH); weeks (clinical) | Physiological HPG support, fertility, sexual processing |
| Gonadorelin (GnRH) | Pituitary direct | Minutes (LH pulse) | Pulsatile GnRH replacement |
| PT-141 | Central MC4R — sexual response | 30–60 min | Acute arousal / erectile function |
| Ipamorelin | GH-axis (separate from HPG) | Acute GH pulse | Body composition support |
Frequently Asked Questions
How is kisspeptin different from HCG for men on TRT?
Can kisspeptin raise testosterone in men with normal baseline levels?
Will kisspeptin affect prostate health?
How long until I notice effects on fertility markers?
Is kisspeptin compatible with HCG?
Does it cause site reactions or hair loss?
Start a Kisspeptin Protocol
Alukard provides physician-supervised men's health protocols with GMP-certified Kisspeptin and GMP-certified compounds with comprehensive hormone panels.
Get ProtocolQuick Facts
- Molecular weight
- 1302 Da
- Sequence length
- 10 aa
- Half-life
- ~28 min IV
- WADA
- Not on prohibited list
- FDA
- Investigational
- Research
- Phase II in HSDD, fertility
Stack Partners
All male physiology applications described on this page are derived from preclinical research, animal models, and limited human case data. None of these uses are FDA-approved indications for Kisspeptin unless otherwise noted. Always work with a physician familiar with peptide therapeutics before beginning a protocol.
Start Your Male Physiology Protocol for Kisspeptin
Alukard provides physician-supervised men's health protocols with GMP-certified compounds with comprehensive hormone panels.
HIPAA Compliant · GMP Certified · Physician Supervised